DK2114130T3 - Dyremodel for ADHD - Google Patents

Dyremodel for ADHD

Info

Publication number
DK2114130T3
DK2114130T3 DK08701838.8T DK08701838T DK2114130T3 DK 2114130 T3 DK2114130 T3 DK 2114130T3 DK 08701838 T DK08701838 T DK 08701838T DK 2114130 T3 DK2114130 T3 DK 2114130T3
Authority
DK
Denmark
Prior art keywords
adhd
animal model
conditions
animal
model
Prior art date
Application number
DK08701838.8T
Other languages
English (en)
Inventor
Susan Clare Stanford
Hugh Gurling
Steven Hunt
Original Assignee
Ucl Business Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucl Business Plc filed Critical Ucl Business Plc
Application granted granted Critical
Publication of DK2114130T3 publication Critical patent/DK2114130T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Environmental Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK08701838.8T 2007-01-17 2008-01-17 Dyremodel for ADHD DK2114130T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0700894.9A GB0700894D0 (en) 2007-01-17 2007-01-17 Animal model
PCT/GB2008/000160 WO2008087419A2 (en) 2007-01-17 2008-01-17 Animal model for adhd

Publications (1)

Publication Number Publication Date
DK2114130T3 true DK2114130T3 (da) 2011-11-14

Family

ID=37810095

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08701838.8T DK2114130T3 (da) 2007-01-17 2008-01-17 Dyremodel for ADHD

Country Status (7)

Country Link
US (1) US20100169994A1 (da)
EP (1) EP2114130B1 (da)
AT (1) ATE516704T1 (da)
DK (1) DK2114130T3 (da)
ES (1) ES2370210T3 (da)
GB (1) GB0700894D0 (da)
WO (1) WO2008087419A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114652287B (zh) * 2022-01-26 2026-02-10 合肥工业大学 非接触式血压监测系统、可读存储介质和电子设备

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191342B1 (en) * 1998-12-02 2001-02-20 Lg Chemical Ltd. Transgenic mice expressing the HIK-ras 4B chimeric gene
GB9924513D0 (en) * 1999-10-15 1999-12-15 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ES2370210T3 (es) 2011-12-13
WO2008087419A3 (en) 2008-09-18
GB0700894D0 (en) 2007-02-21
WO2008087419A2 (en) 2008-07-24
EP2114130B1 (en) 2011-07-20
EP2114130A2 (en) 2009-11-11
US20100169994A1 (en) 2010-07-01
ATE516704T1 (de) 2011-08-15

Similar Documents

Publication Publication Date Title
MX379016B (es) Composiciones y metodos para tratar enfermedad de gaucher.
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
UY34280A (es) Nuevos compuestos que tienen actividad inhibidora frente a la daminoacido oxidasa.
UA109547C2 (uk) Композиція для боротьби з захворюванням рослин і спосіб боротьби з захворюванням рослин
BR112014021104A2 (pt) métodos e composições para o tratamento da doença de huntington
UY34156A (es) Compuestos inhibidores de metaloenzimas
EA200901653A1 (ru) ОПОСРЕДУЕМОЕ PHKi ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC
MY172372A (en) Compositions and methods for lowering triglycerides
TR200906329T1 (tr) Kanser Hastalarında Kemik Gelişimini Desteklemek için A
UY34039A (es) Compuestos fungicidas
BRPI0818732A2 (pt) Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais.
TN2010000096A1 (en) Oxadiazole - and oxazole - substituted benzimidazole - and indole - derivatives as dgat1 inhibitors
BR112017023761A2 (pt) composições e métodos para a produção biológica de metionina
UY33549A (es) Quinolil aminas como agentes inhibidores de las quinasas
BR112013003529A2 (pt) "composição aerada, composição de tratamento capilar método para o tratamento capilar"
EA200802111A1 (ru) Имплантаты для лечения состояний, ассоциируемых с допамином
EA201600442A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
TW200621254A (en) Method for the treatment of attention deficit hyperactivity disorder
EA201100920A1 (ru) Новые гербициды
ECSP14011792A (es) Inhibidores de iap
UY33976A (es) Derivados de pirazolo-pirimidina.
BRPI0910383A2 (pt) compostos de poliuretano e/ou policarboanto de amônio
ATE466854T1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
EA200701995A1 (ru) Способы уменьшения кальцификации
MX2010000956A (es) Derivados de isoftalamida que inhiben actividad de beta-secretasa.